主要产品
digestive system drug Location: Home >  Products >  digestive system drug
Bicyclol (Bicyclol tablets)

                              Bicyclol, Created in China

  Bicyclol is exclusively produced by Beijing Union Pharmaceutical Factory with creation led by Academician Liu Gengtao from Institute of Materia Medica Chinese Academy of Medical Sciences, enjoys a 12-year protection period of new drugs from market launch in November 2001, and is a Class 1.1 new chemical drug with international proprietary intellectual property rights available on the market.
Phase Ⅰ~Ⅳ clinical trials and extensive application after market launch prove that, Bicyclol is suitable for the treatment of chronic viral and non-viral liver disease with elevated serum aminotransferase abnormalities, and is excellent in safety. This drug is recommended for liver protection and anti-inflammatory medication by Chinese Medical Association in Guidelines for Management of Alcoholic Fatty Liver Disease, Guidelines for Management of Non-alcoholic Fatty Liver Disease, The Guideline of Prevention and Treatment for Chronic Hepatitis B, Expert Consensus On Hepatic Inflammation and Its Prevention and other professional guidelines and consensus; included in National Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance Drug List, Army Reasonable Medical Drug List and several provincial NCMS lists. Over 350 academic papers on basic and clinical research with Bicyclol as the theme (nearly 40 SCI indexed journals) have been published at home and abroad.
  Bicyclol is known as a successful example of "Created in China" in chemical and pharmaceutical industry: In 2001, winning the outstanding scientific achievement award of "Ninth Five-Year Plan" national key scientific and technological projects; In 2002, included in high-tech industry development projects of National Development Planning Commission and Beijing high-tech achievement conversion projects, recognized as one of national key new products; In 2003, included in Beijing Spark Program; In 2004, included in Ministry of Science and Technology the Action Plan of Revitalizing Trade through Science and Technology; In 2005, winning the first prize of Beijing Science and Technology Award; In 2007, awarded the 2nd Prize of National Science and Technology Progress Award. Currently, Beijing Union Pharmaceutical Factory has 10 patents for bicyclol invention, and a number of research topics on new mechanisms, new dosage forms, and new applications.

 

  Since market launch, Bicyclol has presented excellent liver health care achievements, creating significant social and economic benefits, and rated as Beijing Famous Brand. With quality advantage, Bicyclol has completed registration and launched into markets in Ukraine, Kazakhstan, Uzbekistan, Tajikistan, Kyrgyzstan, Georgia and Moldova; and has obtained GMP certificate from Ukraine, a member state of Pharmaceutical Inspection Convention (PIC/S) in 2014, providing valuable experiences for the internationalization of innovative medicines.

 

 

Back